All these observations suggest that C1GALT1 expression is an independent prognostic factor for better survival outcomes in NB patients, and could provide complimentary prognostic information in addition to age of patients, differentiation status of tumor, MYCN amplification status, and clinical stages. This evidence concerns the gene C1GALT1 and neoplasm.